Lucia Y Chen
Overview
Explore the profile of Lucia Y Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen L, Thibaud S, Bodnar S, Chari A, Richter J, Cho H, et al.
Blood Adv
. 2024 Nov;
9(1):176-179.
PMID: 39546749
No abstract available.
2.
Chen L, Kothari J
Curr Opin Support Palliat Care
. 2024 Apr;
18(2):92-99.
PMID: 38652455
Purpose Of Review: Bispecific T-cell engager (TCE) therapies are revolutionising the treatment of several haematological malignancies, including B-cell acute lymphoblastic leukaemia, various subtypes of B-cell non-Hodgkin lymphoma, and multiple myeloma....
3.
Agarwal G, Moore S, Sadler R, Varghese S, Turner A, Chen L, et al.
Haematologica
. 2024 Jan;
109(6):1960-1965.
PMID: 38268439
No abstract available.
4.
Aleman A, van Kesteren M, Zajdman A, Srivastava K, Cognigni C, Mischka J, et al.
EBioMedicine
. 2023 Nov;
98:104886.
PMID: 37995467
Background: The real-world impact of bivalent vaccines for wild type (WA.1) and Omicron variant (BA.5) is largely unknown in immunocompromised patients with Multiple Myeloma (MM). We characterize the humoral and...
5.
Klingbeil K, Tang J, Graham D, Lofftus S, Jaiswal A, Lin T, et al.
Cancers (Basel)
. 2023 Sep;
15(18).
PMID: 37760460
Background: Although IGF2BP3 has been implicated in tumorigenesis and poor outcomes in multiple cancers, its role in soft-tissue sarcoma (STS) remains unknown. Preliminary data have suggested an association with IGF2BP3...
6.
Graham D, Qorbani A, Eckardt M, Klingbeil K, Chen L, Chopra S, et al.
Am J Surg Pathol
. 2023 Apr;
47(6):649-660.
PMID: 37057834
Background: Subjective, varying criteria identify "low-grade" dedifferentiation in well-differentiated/dedifferentiated liposarcoma (WD/DDLPS). The value of mitotic rate (MR) in defining DDLPS is not confirmed. We studied all patients with the resection...
7.
Chen L, Gooding S
Front Oncol
. 2022 Nov;
12:1038329.
PMID: 36439455
Resistance to immunomodulatory drugs (IMiDs) is a major cause of treatment failure, disease relapse and ultimately poorer outcomes in multiple myeloma (MM). In order to optimally deploy IMiDs and their...
8.
Chen L, Drayson M, Bunce C, Ramasamy K
Haematologica
. 2022 Nov;
108(6):1476-1486.
PMID: 36373250
Monoclonal gammopathy (MG) is a frequently detected clonal B-cell or plasma-cell disorder. Importantly, every multiple myeloma (MM) case is preceded by MG. Although clinical algorithms now allow earlier treatment of...
9.
Chen L, Eyre T
Eur J Haematol
. 2022 Jul;
109(5):590-592.
PMID: 35871485
B-cell prolymphocytic leukaemia (B-PLL) is an aggressive B-cell lymphoproliferative disease with few clinically proven targeted treatments. Due to the rarity of the condition, there is a paucity of clinical trial...
10.
Crandall C, Chen L, Rodriguez T, Elashoff D, Faubion S, Kling J, et al.
JBMR Plus
. 2021 Aug;
5(8):e10524.
PMID: 34368610
Large-scale studies have not addressed the knowledge level of US resident physicians regarding osteoporosis management. We gauged the knowledge level of family medicine, internal medicine, and obstetrics and gynecology resident...